glp-1 and anesthesia receptor agonists like semaglutide (Ozempic, Wegovy) tirzepatide (Mounjaro) have become incredibly common in diabetes and weight-management care, and they're now showing up more and more in the perioperative setting. These One-Week GLP-1 Agonist Hold Not
Description
[DOI] [PubMed] [Google Scholar] 179
administered GLP-1 inhibits eating via activation of hindbrain GLP-1 receptors [261,694] and suggests a similar mechanism for i.v
Over the past ten years, GLP-1 receptor agonists (GLP-1RAs) such as Ozempic, Wegovy, and Mounjaro have taken the pharmaceutical world by storm
This formulary-driven shift in obesity treatment patterns has important implications for patients
doi: 10.3390/ijms2217945
